Life Science

Life Science

In 2019, Japan's spending on prescription medicines was $87 billion, making it the third largest in the world after China and the United States. The growth of biopharmaceuticals such as anticancer drugs has helped expand the market for prescription medicines.


Life science market to expand due to aging population and digitalization


In Japan, the number of patients with cancer and other diseases is expected to increase as the number of elderly people increases, and the size of the life science market is on the rise. In addition, there have been major innovations in research and drug discovery to treat cancer and dementia, and the digitalization of healthcare is accelerating.


Supporting the healthcare industry nationwide while promoting data utilization


In this report, we focus on the following five government initiatives in the life science industry:

  1. (1)

    Data Health Reform Promotion Project

  2. (2)

    Utilization of medical big data based on the Next-Generation Medical Infrastructure Act

  3. (3)

    Efforts for unmet medical needs

  4. (4)

    Premium for new drug development

  5. (5)

    Support to foreign companies investing in regional areas


In this report, we focus on the following five attractive markets in the life science industry:

  1. (1)

    Pharmaceuticals

  2. (2)

    Medical equipment

  3. (3)

    Preventive healthcare

  4. (4)

    Regenerative medicine

  5. (5)

    Nursing care services

Life Science Report

  1. 1.

    Overview

  2. 2.

    Government Initiatives

  3. 3.

    Attractive Markets

E-mail newsletter subscription

Our E-mail newsletter introduces the latest investment environment information and the trends of foreign companies supported by JETRO. It includes information about seminars by local governments, incentives, examples of setting up business in Japan, topics of deregulation, and introduction of industries.

Contact Us

Investing in Japan

JETRO Worldwide

Was this information useful?

Send